Demand for new lab space has plummeted by more than half since the end of 2021, and life science vacancy rates are the highest they’ve been in a decade amid the biotech industry’s ongoing downturn, […]
Illumina, the largest maker of DNA-sequencing technology and a storied name in the biotechnology industry, named Jacob Thaysen, a 10-year-veteran at life sciences-tools firm Agilent, as its new CEO. The nomination follows a bitter board […]
SAN DIEGO — After starting off the year with lower revenue projections than market analysts had hoped for, San Diego-based genomics giant Illumina lowered expectations again on Wednesday, forecasting annual growth of 1% compared to […]
Micronoma, a San Diego-based biotech startup, was founded on the idea that signatures from microbes that colonize tumors could lead to a blood test to detect cancer. The hypothesis was based on a high-profile Nature […]
SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results […]
Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing […]
LONDON — The European Union on Wednesday issued an antitrust fine of $475 million to the U.S. genetic sequencing giant Illumina for closing its acquisition of cancer detection company Grail before clearing it with regulators. […]
SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and […]
The sudden resignation of Francis deSouza as the CEO of Illumina Sunday represents anything but an orderly transition — and it leaves a black mark on both his six-year tenure and his luckless quest to […]
Just two weeks after surviving an activist investor’s attempt to oust him from Illumina’s board, company CEO Francis deSouza has resigned his roles at the sequencing behemoth, Illumina said Sunday. deSouza stepped down effectively immediately […]
Shareholders in the DNA-sequencing firm Illumina on Thursday voted to replace the company’s chairman with a candidate put forward by the activist investor Carl Icahn, even as Illumina held off an effort to oust other […]
On Thursday Illumina, the largest and most important maker of DNA sequencing technology, whose innovations have changed medicine and have been crucial in our battles with diseases from Covid to cancer, will face a day […]
Brigham and Women’s Hospital will launch a new institute focused on immunology and inflammation, thanks to a $100 million gift, the largest in the hospital’s history. The donation, from Gene Lay, founder and CEO of […]
The Food and Drug Administration warned health care providers Thursday that a security vulnerability in DNA sequencers made by Illumina could allow unauthorized users to access or alter potentially important medical data. The news is […]
Is Illumina the Disney of biotech? Does the Texas two-step work after all? And can you ever really go home again? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech […]
The U.S. Federal Trade Commission on Monday ordered DNA sequencing giant Illumina to divest Grail, a cancer diagnostics firm it purchased without regulatory approval, saying the $7.1 billion acquisition “would stifle competition and innovation in […]
Is AI dictating patient care? What happens when your bank falls apart? And can Illumina endure some shareholder activism? We cover all that and more this week on the 250th episode of “The Readout LOUD,” […]
Illumina, the DNA sequencing giant whose stock has fallen 40% in two years, already had problems. Now it has to contend with Carl Icahn. The granddaddy of activist investors announced Monday morning that he’s taken […]
SAN DIEGO — The first time it happened, veteran real estate broker Ted Jacobs thought it was a fluke. But it didn’t take long for him to realize that the biotech industry’s demand for lab […]
Sanofi’s head of research and development, John Reed, is leaving the pharmaceutical giant to pursue a new opportunity, the company announced Monday. Reed joined Sanofi in 2018, after holding a similar position at Swiss pharma […]
Illumina, the largest maker of DNA sequencing technology, told investors exactly what they didn’t want to hear on Monday. For years, Illumina shares rose steadily as the company led the way on pushing down the […]
SAN DIEGO — Fate Therapeutics, a biotech upstart with big ambitions to use cell-based therapies to treat autoimmune diseases and cancer, is now planning to cut back on both jobs and experimental drugs after an […]
Biosplice’s bid to transform the treatment of everything from arthritis to cancer ran into a snag this week, with the San Diego biotech announcing that its experimental osteoarthritis drug failed to benefit patients in a […]
SAN DIEGO — After a steep drop in its stock price and with mounting competition from rivals, genomics giant Illumina on Thursday launched a new line of high-powered DNA sequencers, ratcheting up the race to […]
Is Illumina a victim of its own success? What makes the FDA change its mind? And how will petrodollars change biotech? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech […]
For Illumina, the leading maker of DNA sequencing equipment, there was bad news and worse news Tuesday. The bad news: The European Commission said it was blocking Illumina’s $8 billion acquisition of Grail, a firm […]
SAN DIEGO — Sequencing behemoth Illumina on Thursday won its case against the Federal Trade Commission in its bid to hold onto Grail, a Bay Area early cancer detection company that the genomics giant acquired […]
SAN DIEGO — From San Diego to New Jersey, biotechs developing new forms of birth control say they’re doubling down on those efforts after Roe v. Wade was overturned — even as the Supreme Court’s […]
SAN DIEGO — More than 40 years ago, Ivor Royston, a brash young assistant professor at University of California, San Diego, made an odd pitch to scientists and pharmaceutical executives across the country: Ditch your […]
Two months after being sued by Illumina over the alleged theft of trade secrets, Bay Area biotech Guardant Health fired back this week, rejecting the DNA sequencing giant’s claims and asking a federal judge to […]
Copyright © 2023 Biotech Networks, LLC
